# OnCo record nct04310592 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04310592/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04310592", "NCT04310592" ;
  schema:name "Natural Killer Cell (CYNK-001) Infusions in Adults with AML"@en ;
  schema:description "A phase 1 trial of CYNK-001 run by Celularity Incorporated, terminated."@en ;
  schema:url <https://onco.cc/trials/nct04310592/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04310592> ;
  onco:status "historic" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  onco:cancers <https://onco.cc/cancers/leukaemia/>, <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:drugs <https://onco.cc/drugs/cynk-001/> ;
  onco:companies <https://onco.cc/companies/celularity/> .